ID

30967

Beschreibung

Rehabilitation Study in MS Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00780455

Link

https://clinicaltrials.gov/show/NCT00780455

Stichworte

Versionen (1)
  1. 08.07.18 08.07.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

8. Juli 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Multiple Sclerosis, Relapsing-Remitting NCT00780455

Englisch

Eligibility Multiple Sclerosis, Relapsing-Remitting NCT00780455

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
female and male patients aged 18 and more;
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
confirmed diagnosis of rrms according to the macdonald or poser criteria;
Beschreibung

Multiple Sclerosis, Relapsing-Remitting

Datentyp

boolean

Alias
UMLS CUI [1]
C0751967
first indication for betaferon treatment (as described in summary of product characteristics (smpc));
Beschreibung

Indication First Betaferon

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0205435
UMLS CUI [1,3]
C0592527
no relapse of multiple sclerosis (ms) in the last two months before the inclusion;
Beschreibung

Multiple sclerosis relapse Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0856120
UMLS CUI [1,2]
C0332197
walking patients having an expanded disability status scale (edss) score between > 1 and </= 4 at the inclusion visit;
Beschreibung

Patients Walking EDSS

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0080331
UMLS CUI [1,3]
C0451246
female of child-bearing potential must agree to practice adequate contraception methods over all the duration of the study;
Beschreibung

Childbearing Potential Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
patient can follow all the study and comply with all procedures of the trial protocol
Beschreibung

Protocol Compliance

Datentyp

boolean

Alias
UMLS CUI [1]
C0525058
laboratory evaluations (i.e. evaluation of hepatic enzymes gammagt, full blood count and differential white blood cell [wbc]) must be available and the results must be normal;
Beschreibung

Evaluation of laboratory test data | Measurement of liver enzyme Gamma-glutamyltransferase normal | Full blood count normal | Differential white blood cell count normal

Datentyp

boolean

Alias
UMLS CUI [1]
C0262707
UMLS CUI [2,1]
C0428321
UMLS CUI [2,2]
C0855631
UMLS CUI [3]
C0427692
UMLS CUI [4]
C0860797
written informed consent.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
any contraindication to betaferon as described in the smpc of the product;
Beschreibung

Medical contraindication Betaferon

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0592527
patient with a previously orthopaedic surgical intervention within the past year of the inclusion;
Beschreibung

Orthopedic Surgical Procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C1136201
patient previously included in this study;
Beschreibung

Study Subject Participation Status

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
patient previously treated within the past 3 months with rebif, avonex or copaxone;
Beschreibung

Rebif | Avonex | Copaxone

Datentyp

boolean

Alias
UMLS CUI [1]
C0752980
UMLS CUI [2]
C0594372
UMLS CUI [3]
C0528175
patient previously treated within the past 12 months with betaferon;
Beschreibung

Betaferon

Datentyp

boolean

Alias
UMLS CUI [1]
C0592527
participation in any clinical trial within the past 30 days involving the investigational drug intake.
Beschreibung

Study Subject Participation Status | Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Multiple Sclerosis, Relapsing-Remitting NCT00780455

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
female and male patients aged 18 and more;
boolean
C0001779 (UMLS CUI [1])
Multiple Sclerosis, Relapsing-Remitting
Item
confirmed diagnosis of rrms according to the macdonald or poser criteria;
boolean
C0751967 (UMLS CUI [1])
Indication First Betaferon
Item
first indication for betaferon treatment (as described in summary of product characteristics (smpc));
boolean
C3146298 (UMLS CUI [1,1])
C0205435 (UMLS CUI [1,2])
C0592527 (UMLS CUI [1,3])
Multiple sclerosis relapse Absent
Item
no relapse of multiple sclerosis (ms) in the last two months before the inclusion;
boolean
C0856120 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Patients Walking EDSS
Item
walking patients having an expanded disability status scale (edss) score between > 1 and </= 4 at the inclusion visit;
boolean
C0030705 (UMLS CUI [1,1])
C0080331 (UMLS CUI [1,2])
C0451246 (UMLS CUI [1,3])
Childbearing Potential Contraceptive methods
Item
female of child-bearing potential must agree to practice adequate contraception methods over all the duration of the study;
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Protocol Compliance
Item
patient can follow all the study and comply with all procedures of the trial protocol
boolean
C0525058 (UMLS CUI [1])
Evaluation of laboratory test data | Measurement of liver enzyme Gamma-glutamyltransferase normal | Full blood count normal | Differential white blood cell count normal
Item
laboratory evaluations (i.e. evaluation of hepatic enzymes gammagt, full blood count and differential white blood cell [wbc]) must be available and the results must be normal;
boolean
C0262707 (UMLS CUI [1])
C0428321 (UMLS CUI [2,1])
C0855631 (UMLS CUI [2,2])
C0427692 (UMLS CUI [3])
C0860797 (UMLS CUI [4])
Informed Consent
Item
written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Medical contraindication Betaferon
Item
any contraindication to betaferon as described in the smpc of the product;
boolean
C1301624 (UMLS CUI [1,1])
C0592527 (UMLS CUI [1,2])
Orthopedic Surgical Procedure
Item
patient with a previously orthopaedic surgical intervention within the past year of the inclusion;
boolean
C1136201 (UMLS CUI [1])
Study Subject Participation Status
Item
patient previously included in this study;
boolean
C2348568 (UMLS CUI [1])
Rebif | Avonex | Copaxone
Item
patient previously treated within the past 3 months with rebif, avonex or copaxone;
boolean
C0752980 (UMLS CUI [1])
C0594372 (UMLS CUI [2])
C0528175 (UMLS CUI [3])
Betaferon
Item
patient previously treated within the past 12 months with betaferon;
boolean
C0592527 (UMLS CUI [1])
Study Subject Participation Status | Investigational New Drugs
Item
participation in any clinical trial within the past 30 days involving the investigational drug intake.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video